CD28 gene polymorphisms and acute cellular rejection after liver transplantation

Area of Science:

• Immunology
• Transplantation
• Genetics

Background:

• The co-stimulatory molecule CD28 is crucial for T-cell immune responses.
• Acute cellular rejection is a significant complication following liver transplantation.

Purpose of the Study:

• To investigate the association between CD28 gene single nucleotide polymorphisms (SNPs) and acute cellular liver transplant rejection.
• To determine if SNPs rs3116487, rs3116494, and rs3116496 influence transplant rejection risk.

Main Methods:

• Retrospective case-control study design.
• Genotyping of CD28 SNPs (rs3116487, rs3116494, rs3116496) in liver transplant recipients.
• Real-time endpoint genotyping for SNP analysis.

Main Results:

• No significant differences in genotype or allele frequencies of the studied CD28 SNPs were observed between patients with and without acute cellular rejection.
• Haplotype analyses also revealed no association between the SNPs and acute cellular liver transplant rejection.

Conclusions:

• The investigated single nucleotide polymorphisms in the CD28 gene are not major genetic contributors to the susceptibility of acute cellular liver transplant rejection.
• Further research may be needed to identify other genetic factors influencing liver transplant outcomes.